7ZO Stock Overview
Develops robotic medical aid for people with gripping limitations.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Tendo AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.0068 |
| 52 Week High | SEK 0.13 |
| 52 Week Low | SEK 0.0046 |
| Beta | 1.08 |
| 11 Month Change | -2.86% |
| 3 Month Change | -30.61% |
| 1 Year Change | -85.83% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -87.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7ZO | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 13.3% | 0.6% | 2.6% |
| 1Y | -85.8% | 5.6% | 4.3% |
Return vs Industry: 7ZO underperformed the German Medical Equipment industry which returned 5.6% over the past year.
Return vs Market: 7ZO underperformed the German Market which returned 4.3% over the past year.
Price Volatility
| 7ZO volatility | |
|---|---|
| 7ZO Average Weekly Movement | 20.8% |
| Medical Equipment Industry Average Movement | 5.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: 7ZO's share price has been volatile over the past 3 months.
Volatility Over Time: 7ZO's weekly volatility has decreased from 30% to 21% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 7 | Sofie Woge | www.tendoforpeople.se |
Tendo AB develops robotic medical aid for people with gripping limitations. The company's Tendo OneGrip is a soft and minimalistic hand exoskeleton, a wearable assistive technology that assists the user to grip and release objects by pulling artificial tendon. The company was founded in 2016 and is based in Lund, Sweden.
Tendo AB Fundamentals Summary
| 7ZO fundamental statistics | |
|---|---|
| Market cap | €615.46k |
| Earnings (TTM) | -€809.20k |
| Revenue (TTM) | €288.12k |
2.1x
P/S Ratio-0.8x
P/E RatioIs 7ZO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7ZO income statement (TTM) | |
|---|---|
| Revenue | SEK 3.28m |
| Cost of Revenue | SEK 0 |
| Gross Profit | SEK 3.28m |
| Other Expenses | SEK 12.49m |
| Earnings | -SEK 9.21m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 100.00% |
| Net Profit Margin | -280.85% |
| Debt/Equity Ratio | 0% |
How did 7ZO perform over the long term?
See historical performance and comparison